Preclinical efficacy of gemcitabine in MLL-rearranged infant acute lymphoblastic leukemia

2020-06-02

Leukemia , Volume 34 - Issue 11 p. 2898- 2902

Additional Metadata
Persistent URL	doi.org/10.1038/s41375-020-0895-9, hdl.handle.net/1765/133978
Journal	Leukemia
Organisation	Department of Pediatrics
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Wander, P., Cheung, L.C., Pinhanҫos, S.S., Jones, L., Kerstjens, M., Arentsen-Peters, S., … Stam, R. (2020). Preclinical efficacy of gemcitabine in MLL-rearranged infant acute lymphoblastic leukemia. Leukemia, 34(11), 2898–2902. doi:10.1038/s41375-020-0895-9

Publication